X

CURES webinar with DOJ now available for on-demand viewing

August 22, 2018
Area(s) of Interest: CURES Drug Prescribing/Dispensing Professional Development & Education 


Effective October 2, 2018, physicians must consult California’s prescription drug monitoring database (the Controlled Substance Utilization Review and Evaluation System, or CURES) – prior to prescribing Schedule II, III or IV controlled substances. All individuals practicing in California who possess both a state regulatory board license authorized to prescribe, dispense, furnish or order controlled substances and a Drug Enforcement Administration Controlled Substance Registration Certificate must be registered to use CURES.

The California Medical Association recently co-hosted a live CURES webinar with the California Department of Justice and the Medical Board of California regarding this new duty-to-consult requirement. The webinar provides an overview of the new mandate and the requirements imposed by the law when checking CURES. It also includes an overview of the registration process and key features of the CURES database.

The webinar is now available for on-demand viewing—free to all interested parties. 

COVID-19
Resources

Resources for physicians and health care providers on the latest news, research and developments.

Stay Informed

Opt in to receive updates on the latest health care news, legislation, and more.

Was this page helpful?